Dale Broadrick bought $206k of BRTX
owner at BioRestorative Therapies, Inc.. 160,000 shares at an average of $1.29, traded Feb 8, 2024, filed Feb 12, 2024.
Score components
- +12Role10% owner
- +12Trade size$206k at market
- +10Relative to holdingsHoldings up 50%
- +18Price context0% above the 52-week low; 80% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -9.7%, 3m -9.7%, 6m -1.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001021771-24-000038, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 8, 2024 | POpen-market purchase Common Stockindirect: Ssee Footnote | +73,959 | $1.25 | $92k | 391,931 | Feb 12, 2024 |
| Feb 9, 2024 | POpen-market purchase Common Stockindirect: See Footnote | +86,041 | $1.32 | $114k | 477,972 | Feb 12, 2024 |
Related signals
Other insiders at BioRestorative Therapies, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | BRTXsell BioRestorative Therapies, Inc. | Dale Broadrick owner | $1,757 1,112 shares | -0% | |
| 36Weak | BRTXbuy BioRestorative Therapies, Inc. | Francisco Silva VP of Research and Development | $10k 8,308 shares | +6% | |
| 42Moderate | BRTXbuy BioRestorative Therapies, Inc. | Dale Broadrick owner | $162k 120,000 shares | +37% | |
| 12Weak | BRTXsell BioRestorative Therapies, Inc. | Dale Broadrick owner | $469 250 shares | -0% | |
| 12Weak | BRTXsell BioRestorative Therapies, Inc. | Dale Broadrick owner | $525 278 shares | -0% | |
| 33Weak | BRTXbuy BioRestorative Therapies, Inc. | Lance Alstodt President, CEO, COB | $903 300 shares | +0% | |
| 33Weak | BRTXbuy BioRestorative Therapies, Inc. | Lance Alstodt President, CEO, COB | $5,375 1,800 shares | +1% | |
| 36Weak | BioRestorative Therapies, Inc. | Lance Alstodt President, CEO, COB | $2,877 1,000 shares | +1% | |
| 41Moderate | BioRestorative Therapies, Inc. | Francisco Silva VP of Research and Development | $2,467 943 shares | +1% | |
| 18Weak | BRTXbuy BioRestorative Therapies, Inc. | Francisco Silva VP of Research and Development | $2,973 806 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.